Work

Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics

Year: 2017

Type: editorial

Abstract: Clinical Pharmacology & Therapeutics (CPT) is an established voice of the discipline, a trusted source of new knowledge showcasing discovery, translation, and application of novel therapeutic paradigms to advance the management of patients and populations. Identifying, evaluating, prioritizing, and disseminating the best science along the discovery-development-regulatory-utilization continuum are responsibilities shared through peer review. To enhance the uniformity of this essential component of quality assurance and innovation, and maximize the value of the journal and its contents to authors, reviewers, and the readership, we review key concepts concerning peer review as it specifically relates to CPT.

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.763

Authors: SA Waldman, A Terzic

Institutions: Thomas Jefferson University, Mayo Clinic

Language: English

Topic: Publishing and Scholarly Communication

Subfield: History and Philosophy of Science

Field: Arts and Humanities

Domain: Social Sciences

Open Access status: green

Funders: Mayo Clinic, National Institutes of Health, National Cancer Institute

Awards: GUCY2C hormone signaling at the intersection of obesity and colorectal cancer(PQ1, G3831044446, Guanylin GUCY2C axis in Colorectal Cancer Initiation, (PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation, Translational Research in Cancer

OpenAlex ID: W2742402355

Cites: 6

Cited by:

Related to: 10